CBD LAB ASIA PHARMACEUTICALS PTE. LTD. (202022183G)

CBD LAB ASIA PHARMACEUTICALS PTE. LTD. is a Sole Proprietorship/ Partnership registered in Singapore under the Unique Entity Number (UEN) 202022183G. The company operates as a Exempt Private Company Limited by Shares and is currently listed as a Struck Off.

Company Overview

CBD LAB ASIA PHARMACEUTICALS PTE. LTD. was incorporated on July, 30 2020 and is regulated by the ACRA. The UEN was officially issued on July, 30 2020.

• Company Name: CBD LAB ASIA PHARMACEUTICALS PTE. LTD.
• Unique Entity Number (UEN): 202022183G
• Issuance Agency: ACRA
• Entity Type: Local Company
• Company Type: Exempt Private Company Limited by Shares
• Company Status: Struck Off
• Number of Officers: 4

Registered Business Address

The registered business address of CBD LAB ASIA PHARMACEUTICALS PTE. LTD. is classified as a LOCAL address and is located at:

Business Classification & Activities

CBD LAB ASIA PHARMACEUTICALS PTE. LTD. is registered under the Singapore Standard Industrial Classification (SSIC) code 46306 - DISTRIBUTION PRODUCTS OF HEALTHY SUPPLEMENT AND COSMETICS.

Former Company Names

The company has previously operated under the following registered names:

• CBD LAB ASIA PHRMACEUTICALS

Statutory & Compliance Information

• Account Due Date: January, 31 2023
• Annual Return Filing Date: February, 11 2022

Audit & Governance

Based on publicly available records, no audit firm information has been disclosed.

Additional Corporate Information

• Business Constitution: N/A
• PAF Constitution: N/A